Company Research Report: Medwise AI
Company Overview
- Name: Medwise AI
- Mission: To empower every healthcare professional to do their best work and provide better care for their patients.
- Founded: No information is available.
- Founders: No information is available.
- Key People:
- Dr. Keith Tsui, Co-Founder
- Dr. Clive Selwyn, Independent Pharmaceutical Physician
- Dr. Rashmi N., Decentralised & Hybrid Clinical Trials Leader
- Yining Yuan, Software Engineer
- Headquarters: London, London WC2H 9JQ, GB
- Number of Employees: 2-10 employees
- Revenue: No information is available.
- Known For: Medwise AI is known for its AI-powered search platform designed specifically for healthcare professionals. It provides quick access to clinical knowledge at the point of care.
Products
- AI-powered Search Platform
- Description: Medwise AI is a next-generation search platform that helps clinicians find answers to their clinical questions within seconds. It supports evidence-based medicine by linking to trusted medical guidelines and resources.
- Key Features:
- Seamless access to clinical knowledge.
- Integration with national knowledge resources, medical societies, and local guidelines.
- Provides only the most relevant information, reducing search time in clinical settings.
- AI-based question answering that improves with usage.
Recent Developments
- Exhibitions and Events:
- Medwise AI recently exhibited at several events, including Expand North Star 2024 in Dubai and Best Practice Show 2024 in Birmingham, showcasing its platform to a range of healthcare professionals and innovators.
- They participated in the Health Elevate event hosted by Barclays in London.
- Medwise AI was highlighted in events like the Cancer Tech Accelerator Demo Day and has relationships with entities like Empact Ventures for HealthTech Series.
- Innovations and Partnerships:
- Medwise AI was selected as the most fundable company at the 8th Health Technology Pitch Event.
- The company has been involved with the National HealthTech Series, in collaboration with various organizations like the NIHR Accelerated Surgical Care HealthTech Research Centre.
- Demonstrates ongoing commitment to expanding awareness and adoption of AI technologies in healthcare.
- Funding and Financial Developments:
- Recently raised a seed round of US$ 202.2K on May 5, 2024.
- Won £1.1M in grants and is currently raising another funding round.
- Platform Enhancements: No specific new features have been highlighted, but their continuous presence in exhibitions and conferences suggests ongoing development and potential new integrations.
Overall, Medwise AI is a company focused on leveraging AI technologies to enhance the efficiency and effectiveness of clinical decision-making in healthcare environments. Their ongoing participations in industry events reflect their commitment to leadership in digital health innovation.